natgillin/translations-raw huggingface dataset:
Brug af Neoclarityn smeltetabletter sammen med mad, drikke og alkohol Neoclarityn smeltetabletter behøver ikke at blive taget med vand eller væske.
Neoclarityn orodispersible tablet with food, drink and alcohol Neoclarityn orodispersible tablet does not need to be taken with water or liquid.
Neoclarityn oral opløsning indeholder sorbitol
Neoclarityn oral solution contains sorbitol
Prævalensen af denne fænotype som er dårlig til at metabolisere var højere blandt voksne negroide end voksne kaukasere (hhv. 18 % og 2 %), sikkerhedsprofilen for disse forsøgspersoner var imidlertid ikke forskellig fra profilen for den almindelige population.
The prevalence of this poor metaboliser phenotype was greater among Black adults than Caucasian adults (18 % vs. 2 %) however the safety profile of these subjects was not different from that of the general population.
Neoclarityn oral opløsning indeholder sorbitol.
Neoclarityn oral solution contains sorbitol.
Herudover kan Neoclarityn smeltetabletter tages med eller uden mad.
Additionally, Neoclarityn orodispersible tablet may be taken with or without a meal.
I et éndosis overkrydsningsstudie af desloratadin blev tablet- og syrup-formuleringerne fundet at være bioækvivalente.
In a single dose, crossover study of desloratadine, the tablet and the syrup formulations were found to be bioequivalent.
I enkeltdosis overkrydsningsstudier af Neoclarityn 5 mg smeltetablet over for konventionelle Neoclarityn 5 mg tabletter var formuleringerne bioækvivalente.
In single-dose crossover studies of Neoclarityn 5 mg orodispersible tablets with Neoclarityn 5 mg conventional tablets, the formulations were bioequivalent.
Neoclarityn oral opløsning leveres i flasker med 30, 50, 60, 100, 120, 150, 225 og 300 ml i type III ravgule glasflasker lukket med et børnesikkert polypropylenskruelåg med en indsats af multi-ply polyethylen.
Neoclarityn oral solution, is supplied in 30, 50, 60, 100, 120, 150, 225 and 300 ml size Type III amber glass bottles closed with a plastic child resistant (C/R) screw closure having a multi-ply polyethylenefaced liner.
Den anbefalede dosis Neoclarityn er to 2,5 mg smeltetabletter lagt i munden en gang dagligt.
The recommended dose of Neoclarityn is two 2.5 mg orodispersible tablets placed in the mouth once a day.
Hvis du har taget for meget Neoclarityn oral opløsning Tag udelukkende Neoclarityn oral opløsning således, som det er ordineret til dig.
If you take more Neoclarityn oral solution than you should Take Neoclarityn oral solution only as it is prescribed for you.
Voksne Efter markedsføring af Neoclarityn er følgende bivirkninger blevet rapporteret:
Adults During the marketing of Neoclarityn, the following side effects were reported as:
Efter markedsføring af Neoclarityn er følgende bivirkninger blevet rapporteret:
During the marketing of Neoclarityn, the following side effects were reported as:
Neoclarityn 2,5 mg smeltetabletter er lys rød, plettet og rund med ”K” trykt på den ene side.
Neoclarityn 2.5 mg orodispersible tablet is light red, speckled, and round with “K” branded on one side.
Neoclarityn var effektivt til at lindre generne ved sæsonbetinget allergisk rhinitis, vist ved den totale score i rhino-konjunktivitis livskvalitetsspørgeskemaet.
Neoclarityn was effective in alleviating the burden of seasonal allergic rhinitis as shown by the total score of the rhino-conjunctivitis quality of life questionnaire.
Dette lægemiddel indeholder 1,4 mg phenylalanin per 2,5 mg Neoclarityn smeltetablet.
This product contains 1.4 mg of phenylalanine per 2.5 mg dose of Neoclarityn orodispersible tablet.
I et klinisk farmakologisk studie forstærkede Neoclarityn-tabletter indtaget sammen med alkohol ikke alkohols præstationshæmmende virkninger (se pkt.
In a clinical pharmacology trial, Neoclarityn tablets taken concomitantly with alcohol did not potentiate the performance impairing effects of alcohol (see section 5.1).
Navn og adresse på den fremstiller, der er ansvarlig for batchfrigivelse af filmovertrukne tabletter
Name and address of the manufacturer responsible for batch release for film coated tablets
Neoclarityn 5 mg smeltetabletter er lys rød, plettet og rund med ”A” trykt på den ene side.
Neoclarityn 5 mg orodispersible tablet is light red, speckled, and round with “A” branded on one side.
Tag ikke lægemidlet, hvis du bemærker ændringer i udseendet af Neoclarityn smeltetabletter.
Do not use this medicine if you notice any change in the appearance of Neoclarityn orodispersible tablet.
Dette lægemiddel indeholder 2,9 mg phenylalanin per 5 mg Neoclarityn smeltetablet.
This product contains 2.9 mg of phenylalanine per 5 mg dose of Neoclarityn orodispersible tablet.
Børn i alderen 1 til 5 år: 2,5 ml (1,25 mg) Neoclarityn oral opløsning en gang daglig.
Children 1 through 5 years of age: 2.5 ml (1.25 mg) Neoclarityn oral solution once a day.
Neoclarityn-tabletter lindrede effektivt generne ved sæsonbetonet allergisk rhinitis, vist ved den totale score i rhino-konjunktivitis livskvalitetsspørgeskemaet.
Neoclarityn tablets were effective in alleviating the burden of seasonal allergic rhinitis as shown by the total score of the rhino-conjunctivitis quality of life questionnaire.
Hos de fleste børn og voksne var bivirkningerne i kliniske studier med Neoclarityn nogenlunde de samme som ved en placeboopløsning eller placebotablet.
In clinical studies in most children and adults, side effects with Neoclarityn were about the same as with a dummy solution or tablet.
Voksne og unge (i alderen 12 år og derover) Den anbefalede dosis af Neoclarityn er en tablet en gang dagligt.
Adults and adolescents (12 years of age and over) The recommended dose of Neoclarityn is one tablet once a day.
Kontakt lægen, apoteket eller sundhedspersonalet, før du tager Neoclarityn.
Talk to your doctor, pharmacist or nurse before taking Neoclarityn: - if you have poor kidney function.
Brug af Neoclarityn sammen med mad, drikke og alkohol Neoclarityn kan tages med eller uden mad.
Neoclarityn with food, drink and alcohol Neoclarityn may be taken with or without a meal.
Virkningen af Neoclarityn oral opløsning er ikke vurderet i særlige studier hos børn.
Efficacy of Neoclarityn oral solution has not been investigated in separate paediatric trials.
Børn i alderen 6 til 11 år: den anbefalede dosis Neoclarityn er en 2,5 mg smeltetablet lagt i munden en gang dagligt.
Children 6 to 11 years of age: the recommended dose of Neoclarityn is one 2.5 mg orodispersible tablet placed in mouth once a day.
Neoclarityn indeholder lactose
Neoclarityn contains lactose
Det skal du vide, før du begynder at tage Neoclarityn
What you need to know before you take Neoclarityn
Brug af Neoclarityn oral opløsning sammen med mad, drikke og alkohol Neoclarityn kan tages med eller uden mad.
Neoclarityn oral solution with food, drink and alcohol Neoclarityn may be taken with or without a meal.
Neoclarityn er et lægemiddel mod allergi, som ikke gør dig døsig.
Neoclarityn is an antiallergy medicine that does not make you drowsy.
Neoclarityn leveres i blistre af formstøbt blisterfilm med folielåg.
Neoclarityn is supplied in blisters comprised of laminate blister film with foil lidding.
Neoclarityn indeholder:
What Neoclarityn contains
Det skal du vide, før du begynder at tage Neoclarityn oral opløsning
What you need to know before you take Neoclarityn oral solution
Med hensyn til varigheden af behandlingen, vil din læge bestemme hvilken type allergisk snue, du lider af, og vil fastsætte, hvor længe du skal tage Neoclarityn oral opløsning.
Regarding the duration of treatment, your physician will determine the type of allergic rhinitis you are suffering from and will determine for how long you should take Neoclarityn oral solution.
Med hensyn til varigheden af behandlingen, vil din læge bestemme hvilken type allergisk snue, du lider af, og vil fastsætte, hvor længe du skal tage Neoclarityn.
Regarding the duration of treatment, your physician will determine the type of allergic rhinitis you are suffering from and will determine for how long you should take Neoclarityn.
Neoclarityn 5 mg filmovertrukne tabletter er pakket i enkeltdosisblisterpakninger med 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50 eller 100 tabletter.
Neoclarityn 5 mg film-coated tablets are packed in blisters in packs of 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50 or 100 tablets.
Børn i alderen 6 til 11 år: 5 ml (2,5 mg) Neoclarityn oral opløsning en gang daglig.
Children 6 through 11 years of age: 5 ml (2.5 mg) Neoclarityn oral solution once a day.
Med hensyn til varigheden af behandlingen, vil din læge bestemme hvilken type allergisk snue, du lider af, og vil fastsætte, hvor længe du skal tage Neoclarityn smeltetabletter.
Regarding the duration of treatment, your physician will determine the type of allergic rhinitis you are suffering from and will determine for how long you should take Neoclarityn orodispersible tablets.
Ved den anbefalede dosis i kliniske studier omfattende voksne og unge ved en række indikationer omfattende allergisk rhinitis og kronisk idiopatisk urticaria, blev bivirkninger med Neoclarityn rapporteret hos 3 % flere patienter end hos dem, der behandledes med placebo.
At the recommended dose, in clinical trials involving adults and adolescents in a range of indications including allergic rhinitis and chronic idiopathic urticaria, undesirable effects with Neoclarityn were reported in 3 % of patients in excess of those treated with placebo.
Sikkerhed og virkning af Neoclarityn 0,5 mg/ml oral opløsning hos børn under 1 år er ikke klarlagt.
The safety and efficacy of Neoclarityn 0.5 mg/ml oral solution in children below the age of 1 year have not been established.
Vurderet på baggrund af kliniske studier påvirker Neoclarityn ikke eller kun i ubetydelig grad evnen til at føre motorkøretøj og betjene maskiner.
Neoclarityn has no or negligible influence on the ability to drive and use machines based on clinical trials.
Lægen bør være opmærksom på, at de fleste tilfælde af rhinitis hos børn under 2 år skyldes infektioner (se pkt.
The prescriber should be aware that most cases of rhinitis below 2 years of age are of infectious origin (see section 4.4) and there are no data supporting the treatment of infectious rhinitis with Neoclarityn.
I forbindelse med dosisjusteringsstudierne hos børn underbygger de farmakokinetiske data for Neoclarityn smeltetabletter imidlertid brugen af 2,5 mg dosen til børn i alderen 6 til 11 år.
Neoclarityn 2.5 mg tablets has not been evaluated in paediatric patients however in conjunction with the dose finding studies in paediatrics, the pharmacokinetics data for Neoclarityn orodispersible tablets supports the use of the 2.5 mg dose in paediatric patients 6 to 11 years of age.
Neoclarityn-tabletter, givet i en enkelt daglig dosis på 7,5 mg til voksne og unge, påvirkede ikke den psykomotoriske præstationsevne i kliniske studier.
Neoclarityn tablets given at a single daily dose of 7.5 mg to adults and adolescents did not affect psychomotor performance in clinical trials.
Sådan skal du tage Neoclarityn
How to take Neoclarityn
Det skal du vide, før du begynder at tage Neoclarityn smeltetabletter
What you need to know before you take Neoclarityn orodispersible tablet
Neoclarityn oral opløsning indeholder:
What Neoclarityn oral solution contains
Neoclarityn 0,5 mg/ml oral opløsning
Neoclarityn 0.5 mg/ml oral solution
Neoclarityn oral opløsning er et lægemiddel mod allergi, som ikke gør dig døsig.
Neoclarityn oral solution is an antiallergy medicine that does not make you drowsy.
Sådan skal du tage Neoclarityn oral opløsning
How to take Neoclarityn oral solution
Neoclarityn bør anvendes med forsigtighed til patienter med svær nyreinsufficiens (se pkt.
In the case of severe renal insufficiency, Neoclarityn should be used with caution (see section 5.2).
Neoclarityn smeltetabletter er et lægemiddel mod allergi, som ikke gør dig døsig.
Neoclarityn orodispersible tablet is an antiallergy medicine that does not make you drowsy.
Neoclarityn, givet i en enkelt daglig dosis på 7,5 mg, påvirkede ikke den psykomotoriske præstationsevne i kliniske studier.
Neoclarityn given at a single daily dose of 7.5 mg did not affect psychomotor performance in clinical trials.
I kliniske studier ved en række indikationer omfattende allergisk rhinitis og kronisk idiopatisk urticaria, ved den anbefalede dosis på 5 mg daglig, blev bivirkninger med Neoclarityn-tabletter rapporteret hos 3 % flere patienter end hos dem, der behandledes med placebo.
In clinical trials in a range of indications including allergic rhinitis and chronic idiopathic urticaria, at the recommended dose of 5 mg daily, undesirable effects with Neoclarityn tablets were reported in 3 % of patients in excess of those treated with placebo.
Neoclarityn-tabletter, givet i en enkelt daglig dosis på 7,5 mg, påvirkede ikke den psykomotoriske præstationsevne i kliniske studier.
Neoclarityn tablets given at a single daily dose of 7.5 mg did not affect psychomotor performance in clinical trials.
Neoclarityn er indiceret hos voksne, unge i alderen 12 år og derover samt børn i alderen 6 til 11 år til lindring af symptomer i forbindelse med: - allergisk rhinitis (se pkt.
Neoclarityn is indicated in adults, adolescents aged 12 years and older and children aged 6 - 11 years old for the relief of symptoms associated with: - allergic rhinitis (see section 5.1) - urticaria (see section 5.1)
EU/1/00/161/001 1 tablet EU/1/00/161/002 2 tabletter EU/1/00/161/003 3 tabletter EU/1/00/161/004 5 tabletter EU/1/00/161/005 7 tabletter EU/1/00/161/006 10 tabletter EU/1/00/161/007 14 tabletter EU/1/00/161/008 15 tabletter EU/1/00/161/009 20 tabletter EU/1/00/161/010 21 tabletter EU/1/00/161/011 30 tabletter EU/1/00/161/012 50 tabletter EU/1/00/161/013 100 tabletter
EU/1/00/161/001 1 tablet EU/1/00/161/002 2 tablets EU/1/00/161/003 3 tablets EU/1/00/161/004 5 tablets EU/1/00/161/005 7 tablets EU/1/00/161/006 10 tablets EU/1/00/161/007 14 tablets EU/1/00/161/008 15 tablets EU/1/00/161/009 20 tablets EU/1/00/161/010 21 tablets EU/1/00/161/011 30 tablets EU/1/00/161/012 50 tablets EU/1/00/161/013 100 tablets
Voksne og unge (i alderen 12 år og derover) Den anbefalede dosis Neoclarityn er 10 ml (5 mg) oral opløsning en gang dagligt.
Adults and adolescents (12 years of age and over) The recommended dose of Neoclarityn is 10 ml (5 mg) oral solution once a day.
Sådan virker Neoclarityn
How Neoclarityn works
Voksne og unge (i alderen 12 år og derover) Den anbefalede dosis Neoclarityn er en 5 mg smeltetablet lagt i munden en gang dagligt.
Adults and adolescents (12 years of age and over) The recommended dose of Neoclarityn is one 5 mg orodispersible tablet placed in the mouth once a day.
EU/1/00/161/059 30 ml med en måleske EU/1/00/161/060 50 ml med en måleske EU/1/00/161/061 60 ml med en måleske EU/1/00/161/062 100 ml med en måleske EU/1/00/161/063 120 ml med en måleske EU/1/00/161/064 150 ml med en måleske EU/1/00/161/067 150 ml med en oral sprøjte EU/1/00/161/065 225 ml med en måleske EU/1/00/161/066 300 ml med en måleske
EU/1/00/161/059 30 ml with 1 spoon EU/1/00/161/060 50 ml with 1 spoon EU/1/00/161/061 60 ml with 1 spoon EU/1/00/161/062 100 ml with 1 spoon EU/1/00/161/063 120 ml with 1 spoon EU/1/00/161/064 150 ml with 1 spoon EU/1/00/161/067 150 ml with 1 oral syringe EU/1/00/161/065 225 ml with 1 spoon EU/1/00/161/066 300 ml with 1 spoon
Neoclarityn smeltetabletter leveres i enkeltdosisblistre af formstøbt blisterfilm med folielåg.
Neoclarityn orodispersible tablets are supplied in unit dose blisters comprised of laminate blister film with foil lidding.
Neoclarityn anvendes også til at lindre symptomerne i forbindelse med nældefeber (en hudlidelse forårsaget af allergi).
Neoclarityn is also used to relieve the symptoms associated with urticaria (a skin condition caused by an allergy).
Neoclarityn er indiceret hos voksne, unge og børn over 1 år til lindring af symptomer i forbindelse med: - allergisk rhinitis (se pkt.
Neoclarityn is indicated in adults, adolescents and children over the age of 1 year for the relief of symptoms associated with: - allergic rhinitis (see section 5.1) - urticaria (see section 5.1)
Sikkerhed og virkning af Neoclarityn 5 mg filmovertrukne tabletter hos børn under 12 år er ikke klarlagt.
The safety and efficacy of Neoclarityn 5 mg film-coated tablets in children below the age of 12 years have not been established.
Neoclarityn smeltetabletter er pakket i enkeltdosisblisterpakninger med 5, 6, 10, 12, 15, 18, 20, 30, 50, 60, 90 eller 100 smeltetabletter.
Neoclarityn orodispersible tablet is packed in unit dose blisters in packs of 5, 6, 10, 12, 15, 18, 20, 30, 50, 60, 90 and 100 doses of orodispersible tablet.
Neoclarityn oral opløsning anvendes også til at lindre symptomerne ved nældefeber (en hudlidelse forårsaget af allergi).
Neoclarityn oral solution is also used to relieve the symptoms associated with urticaria (a skin condition caused by an allergy).
Neoclarityn smeltetabletter anvendes også til at lindre symptomerne i forbindelse med nældefeber (en hudlidelse forårsaget af allergi).
Neoclarityn orodispersible tablet is also used to relieve the symptoms associated with urticaria (a skin condition caused by an allergy).
PAKNING MED 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50, 100 TABLETTER
BOX OF 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50, 100 TABLETS
Neoclarityn 5 mg tablet desloratadin
Neoclarityn 5 mg tablet desloratadine
Hos voksne og unge patienter med allergisk rhinitis lindrede Neoclarityn-tabletter effektivt symptomer såsom nysen, næseflåd og -kløe, samt øjenkløe, tåreflåd og rødme samt kløe i ganen.
In adult and adolescent patients with allergic rhinitis, Neoclarityn tablets were effective in relieving symptoms such as sneezing, nasal discharge and itching, as well as ocular itching, tearing and redness, and itching of palate.
Neoclarityn 0,5 mg/ml oral opløsning desloratadin
Neoclarityn 0.5 mg/ml oral solution desloratadine
Tag ikke Neoclarityn smeltetabletter - hvis du er allergisk over for desloratadin eller et af de øvrige indholdsstoffer i Neoclarityn
Do not take Neoclarityn orodispersible tablet - if you are allergic to desloratadine, or any of the other ingredients of this medicine (listed in section 6) or to loratadine.
Tag ikke Neoclarityn oral opløsning - hvis du er allergisk over for desloratadin eller et af de øvrige indholdsstoffer i Neoclarityn
Do not take Neoclarityn oral solution - if you are allergic to desloratadine, or to any of the other ingredients of this medicine (listed in section 6) or to loratadine.
Pakninger med 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50 eller 100 tabletter.
Packs of 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50, 100 tablets.
Sikkerhed og virkning af Neoclarityn 2,5 mg smeltetabletter hos børn under 6 år er ikke klarlagt.
The safety and efficacy of Neoclarityn 2.5 mg orodispersible tablets in children below the age of 6 years have not been established.
Hvis du har taget for mange Neoclarityn smeltetabletter Tag udelukkende Neoclarityn smeltetabletter således, som det er ordineret til dig.
If you take more Neoclarityn orodispersible tablet than you should Take Neoclarityn orodispersible tablet only as prescribed for you.
Det skal du vide, før du begynder at tage Neoclarityn oral opløsning Sådan skal du tage Neoclarityn oral opløsning Bivirkninger
What Neoclarityn oral solution is and what it is used for What you need to know before you take Neoclarityn oral solution How to take Neoclarityn oral solution Possible side effects
I kliniske studier ved en række indikationer omfattende allergisk rhinitis og kronisk idiopatisk urticaria, ved den anbefalede dosis på 5 mg daglig, blev bivirkninger med Neoclarityn rapporteret hos
In clinical trials in a range of indications including allergic rhinitis and chronic idiopathic urticaria, at the recommended dose of 5 mg daily, undesirable effects with Neoclarityn were reported in 3 % of patients in excess of those treated with placebo.
Neoclarityn er indiceret hos voksne og unge i alderen 12 år og derover til lindring af symptomer i forbindelse med: - allergisk rhinitis (se pkt.
Neoclarityn is indicated in adults and adolescents aged 12 years and older for the relief of symptoms associated with: - allergic rhinitis (see section 5.1) - urticaria (see section 5.1)
Hos patienter med allergisk rhinitis lindrede Neoclarityn-tabletter effektivt symptomer såsom nysen, næseflåd og -kløe, samt øjenkløe, tåreflåd og rødme og kløe i ganen.
In patients with allergic rhinitis, Neoclarityn tablets were effective in relieving symptoms such as sneezing, nasal discharge and itching, as well as ocular itching, tearing and redness, and itching of palate.
Tag ikke Neoclarityn - hvis du er allergisk over for desloratadin eller et af de øvrige indholdsstoffer i Neoclarityn
Do not take Neoclarityn - if you are allergic to desloratadine, or any of the other ingredients of this medicine (listed in section 6) or to loratadine.
Hos patienter med allergisk rhinitis lindrede Neoclarityn effektivt symptomer såsom nysen, næseflåd og -kløe, samt øjenkløe, tåreflåd og rødme og kløe i ganen.
In patients with allergic rhinitis, Neoclarityn was effective in relieving symptoms such as sneezing, nasal discharge and itching, as well as ocular itching, tearing and redness, and itching of palate.
Sådan skal du tage Neoclarityn smeltetabletter
How to store Neoclarityn orodispersible tablet
Neoclarityn 5 mg filmovertrukne tabletter
Neoclarityn 5 mg film-coated tablets
Sikkerhed og virkning af Neoclarityn 5 mg smeltetabletter hos børn under 12 år er ikke klarlagt.
The safety and efficacy of Neoclarityn 5 mg orodispersible tablets in children below the age of 12 years have not been established.
Neoclarityn smeltetabletter indeholder:
What Neoclarityn orodispersible tablet contains
EU/1/00/161/035 5 smeltetabletter EU/1/00/161/036 6 smeltetabletter EU/1/00/161/037 10 smeltetabletter EU/1/00/161/038 12 smeltetabletter EU/1/00/161/039 15 smeltetabletter EU/1/00/161/040 18 smeltetabletter EU/1/00/161/041 20 smeltetabletter EU/1/00/161/042 30 smeltetabletter EU/1/00/161/043 50 smeltetabletter EU/1/00/161/044 60 smeltetabletter EU/1/00/161/045 90 smeltetabletter EU/1/00/161/046 100 smeltetabletter
EU/1/00/161/035 5 orodispersible tablets EU/1/00/161/036 6 orodispersible tablets EU/1/00/161/037 10 orodispersible tablets EU/1/00/161/038 12 orodispersible tablets EU/1/00/161/039 15 orodispersible tablets EU/1/00/161/040 18 orodispersible tablets EU/1/00/161/041 20 orodispersible tablets EU/1/00/161/042 30 orodispersible tablets EU/1/00/161/043 50 orodispersible tablets EU/1/00/161/044 60 orodispersible tablets EU/1/00/161/045 90 orodispersible tablets EU/1/00/161/046 100 orodispersible tablets
Hvis du holder op med at tage Neoclarityn oral opløsning Spørg lægen, apotekspersonalet eller sundhedspersonalet, hvis der er noget du er i tvivl om.
If you stop taking Neoclarityn oral solution If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Det skal du vide, før du begynder at tage Neoclarityn smeltetabletter Sådan skal du tage Neoclarityn smeltetabletter Bivirkninger
What Neoclarityn orodispersible tablet is and what it is used for What you need to know before you take Neoclarityn orodispersible tablet How to take Neoclarityn orodispersible tablet Possible side effects
Hvis du holder op med at tage Neoclarityn smeltetabletter Spørg lægen, apotekspersonalet eller sundhedspersonalet, hvis der er noget du er i tvivl om.
If you stop taking Neoclarityn orodispersible tablet If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Neoclarityn 5 mg filmovertrukne tabletter desloratadin
Neoclarityn 5 mg film-coated tablets desloratadine
Neoclarityn 2,5 mg smeltetabletter desloratadin
Neoclarityn 2.5 mg orodispersible tablets desloratadine